Inhibition of Voriconazole Metabolism by Chloramphenicol in an Adolescent with Central Nervous System Aspergillosis

ABSTRACT For an adolescent with bacterial meningitis and subsequent cerebral aspergillosis, intravenous voriconazole dose requirements substantially decreased during coadministration with intravenous chloramphenicol and considerably rose after discontinuation of the antibiotic. In agreement with in vitro evidence, these data suggest that chloramphenicol is a rather significant inhibitor of hepatic CYP3A4 and/or CYP2C19.

[1]  D. Denning,et al.  Voriconazole plasma monitoring , 2008, Archives of Disease in Childhood.

[2]  M. Falagas,et al.  Old antibiotics for infections in critically ill patients , 2007, Current opinion in critical care.

[3]  J. Burhenne,et al.  Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma , 2007, Pediatric blood & cancer.

[4]  D. Andes,et al.  Voriconazole Therapeutic Drug Monitoring , 2006, Antimicrobial Agents and Chemotherapy.

[5]  G. Klintmalm,et al.  Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: A Prospective, Multicenter, Observational Study , 2006, Transplantation.

[6]  W. Haefeli,et al.  Opposite effects of short‐term and long‐term St John's wort intake on voriconazole pharmacokinetics , 2005, Clinical pharmacology and therapeutics.

[7]  M. Karlsson,et al.  Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration , 2004, Antimicrobial Agents and Chemotherapy.

[8]  N. Wood,et al.  Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. , 2003, British journal of clinical pharmacology.

[9]  N. Wood,et al.  Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole. , 2003, British journal of clinical pharmacology.

[10]  Ji-Young Park,et al.  Chloramphenicol Is a Potent Inhibitor of Cytochrome P450 Isoforms CYP2C19 and CYP3A4 in Human Liver Microsomes , 2003, Antimicrobial Agents and Chemotherapy.

[11]  D A Smith,et al.  Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[12]  B. Ogutu,et al.  Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration. , 2002, British journal of clinical pharmacology.

[13]  G. Friedman,et al.  Interaction of chloramphenicol and the calcineurin inhibitors in renal transplant recipients , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[14]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[15]  J. Perfect,et al.  Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children , 2002, The Pediatric infectious disease journal.

[16]  S. Clarke,et al.  Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance , 2000, European Journal of Clinical Pharmacology.

[17]  D. Taber,et al.  Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. , 2000, Transplantation proceedings.

[18]  L. Shaw,et al.  Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. , 1998, Transplantation.

[19]  D. B. Duignan,et al.  Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[20]  J. Halpert,et al.  Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. , 1985, Molecular pharmacology.

[21]  A. Yacobi,et al.  Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats. , 1984, The Journal of pharmacology and experimental therapeutics.

[22]  M. Gibaldi,et al.  Interaction of chloramphenicol with phenytoin and phenobarbital; Case report , 1978, Clinical pharmacology and therapeutics.